The renin-angiotensin system plays a pivotal role in blood pressure re
gulation. Recent molecular biological findings led to the new concept
that in addition to the classic endocrine system, local tissue systems
may also play an important role in cardiovascular diseases such as hy
pertension. In particular, the brain renin-angiotensin system was show
n to influence the central control of blood pressure and is thought to
contribute to the hypertensive phenotype of genetically hypertensive
rat models. To identify the physiological role of these local systems,
we established an antisense strategy to downregulate the expression o
f the precursor hormone angiotensinogen (AOGEN) in cell culture, which
can also be used to establish transgenic rat lines. Plasmids encoding
an RNA sequence complementary to the rat AOGEN mRNA under control of
different viral and tissue-specific promoters were constructed and tra
nsfected into an AOGEN-expressing cell line. A competitive reverse tra
nscription-polymerase chain reaction method was established for the qu
antification of AOGEN mRNA. Depending on the level of antisense RNA, t
he expression of the AOGEN gene was reduced down to 22% of control lev
els. Furthermore, the secretion of AOGEN protein was totally abolished
. These results clearly demonstrate that the antisense constructs used
are functional in reducing the AOGEN gene expression in vivo and can
be used for the production of transgenic rats.